Psychedelic drug therapies hold great promise, need more research funding: scientists
Mark Haden, an adjunct professor at the University of British Columbia, says there is a “psychedelic renaissance” underway in the research community, adding it is pressing for Ottawa to look at funding science into alternative therapies for patients.
Haden and other researchers support a House of Commons petition, sponsored by Liberal MP Nathaniel Erskine-Smith, calling for the minister to explore multi-year funding on psychedelic research projects at hospitals and universities.
Erskine-Smith says it is important to explore treatments that could help Canadians suffering from mental health issues.
WATCH: Could LSD, magic mushrooms curb domestic violence? Research finds ‘calming’ effect
A spokesperson for Petitpas Taylor says the Canadian Institutes of Health Research previously authorized a clinical trial involving MDMA – a psychedelic substance commonly known as ecstasy.
© 2017 The Canadian Press